𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib

✍ Scribed by Dietmar Steverding; Xia Wang

Book ID
119913109
Publisher
BioMed Central
Year
2009
Tongue
English
Weight
173 KB
Volume
2
Category
Article
ISSN
1756-3305

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Synergistic anti-proliferative and pro-a
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells
✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 356 KB πŸ‘ 1 views

## Abstract The proteasome plays a pivotal role in the turnover of regulatory transduction proteins induced by activated cell membrane growth factor receptors. The epidermal growth factor receptor (EGFR) pathway is crucial in the development and progression of human epithelial cancers. Proteasome i

Synergistic anti-proliferative and pro-a
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells
✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 29 KB πŸ‘ 1 views

## Abstract The article to which this erratum refers was published in J Cell Physiol (2008) 216: 698–707. Β© 2008 Wiley‐Liss, Inc. DOI: 10.1002/jcp.21444